http://www.avibio.com/ AVI BioPharma News and Press Releases Mon, 11 Aug 2008 06:00:00 PDT http://www.avibio.com/pr/pr387.php CORVALLIS, OR — August 11, 2008 — AVI BioPharma, Inc. (NASDAQ: AVII) today reported financial results for the three and six months ending June 30, 2008. The Company also reported that it has received approval from the Medicine and Healthcare Product Regulatory Agency (MHRA) to conduct its systemic trial of AVI-4658 in the treatment of Duchenne Muscular Dystrophy in the United Kingdom and also updated the new additions to its senior management team. [more...] Mon, 11 Aug 2008 06:00:00 PDT http://www.avibio.com/pr/pr387.php http://www.avibio.com/pr/pr386.php CORVALLIS, OR — August 7, 2008 — AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based drugs, today announced that the Company will hold a conference call to report its second quarter 2008 financial results on Monday, August 11, 2008, at 9:30 a.m. Eastern time (6:30 a.m. Pacific time). [more...] Thu, 7 Aug 2008 06:30:00 PDT http://www.avibio.com/pr/pr386.php http://www.avibio.com/pr/pr385.php CORVALLIS, OR — August 4, 2008 — AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based drugs, today announced that Dr. Leslie Hudson, CEO, will present an update on the transitioning of AVI from an antisense pioneer into an RNA-based drug discovery and development company. [more...] Mon, 4 Aug 2008 06:30:00 PDT http://www.avibio.com/pr/pr385.php